Ori Yehudai: "I took a company worth $3 million and sold it to IFF at $7.1 
billion in 2018. In my opinion, the success of our cannabis company will be to 
build an industrial pharmaceutical company with the strictest standards, we had 
two such plants, and I know what that means. Some of the companies operating in 
the market today do not necessarily know what it means to comply with standards 
and how to build a long-lasting successful venture."

Photo - https://mma.prnewswire.com/media/891534/Sade_Group.jpg 

Frutarom former CEO and shareholder, Ori Yehudai, is joining a new venture in 
the cannabis world. After selling the successful company last year for $7.1 
billion, he is now investing as partner and assuming as an active chairman, 
leading the Sade Group to triumph. He is joined in the company of 
multi-billionaire, international businessman, Yakir Gabay, a German real estate 
tycoon whom is a major shareholder and partner in the Sade Group. Also joined 
by businessman, Ran Nussbaum, co-founder and managing partner of The Pontifax 
Group, a capital firm investing in pharmaceutical and life sciences companies. 
With joint efforts, the company is currently raising funds to expand into new 
acquisitions. Sources close to the company expect that it will soon raise more 
significant funds, which will enable it to implement plans to expand the 
business to markets throughout Europe and other markets.

Sade Group is a full-vertical company that covers from seed to cannabis-based 
pharmaceutical products. The company is geared to be one of the most advanced, 
quality-driven medicinal cannabis companies today. Their knowledge of the 
cannabis plant - from its genetics to the final product - enable them to bring 
superior products to market and advance patient care. The Sade Group expanded 
on its knowledge of growing for research purposes - and up-scaled it to global 
and commercial growing. Now planning to develop unique strains based on 
clinical research, and the transition to industrial production will ultimately 
allow the company to build highly recognized brands. The company plans to 
operate channels in the fields of medicine, food and cosmetics.

Ori Yehudai added: "After deep examination of this very young industry, I have 
finally found a company with a mature strategy and a skilled multidisciplinary 
team that will make Sade the de-facto leader in this space. In the next six 
months, we will complete the company's foundation, so that it can become one of 
the world's leading companies, we will need substantial funding and we will 
mobilize it."

For further info: 

Tel #305-933-4646 / E-mail: sadegroupinfo@gmail.com 

SOURCE: Sade Group